Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – N-c doai
Patent
1996-01-16
1997-12-16
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
N-c doai
560164, 514489, A61K 3127
Patent
active
056985886
ABSTRACT:
The pure enantiomeric forms, as well as enantiomeric mixtures excluding the racemic mixture of monocarbamates of 2-phenyl-1,2-ethanediol substituted with more than one halogen atom on the phenyl ring and dicarbamates of 2-phenyl-1,2-ethanediol substituted with more than one halogen atom on the phenyl ring have been found to be effective in the treatment of disorders of the central nervous system.
REFERENCES:
patent: 2884444 (1959-04-01), Berger
patent: 2937119 (1960-05-01), Berger et al.
patent: 3144389 (1964-08-01), Bossinger
patent: 3248418 (1966-04-01), Bossinger
patent: 3265727 (1966-08-01), Bossinger
patent: 3265728 (1966-08-01), Bossing et al.
patent: 3313692 (1967-04-01), Bossinger
patent: 3313696 (1967-04-01), Bossinger
patent: 3313697 (1967-04-01), Bossinger
patent: 3313699 (1967-04-01), Bossinger
patent: 3313700 (1967-04-01), Bossinger
patent: 3509162 (1970-04-01), Bsendorfetal
Bergen, "J. Pharm. Exp. Ther." 104, 229-233 (1952).
DeSala et al. "Toxicology and Applied Pharmacology", 2, 397-402 (1960).
Choi Yong Moon
Kim Min Woo
Shippen Michael L.
Yukong Limited
LandOfFree
Halogen substituted carbamate compounds from 2-phenyl-1,2-ethane does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Halogen substituted carbamate compounds from 2-phenyl-1,2-ethane, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Halogen substituted carbamate compounds from 2-phenyl-1,2-ethane will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-206784